Sotorasib monotherapy (KRAS G12C+ NSCLC, 2L+)

Name: Sotorasib monotherapy (KRAS G12C+ NSCLC, 2L+) - OpenOnco
License: https://creativecommons.org/licenses/by/4.0/

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Components	`DRUG-SOTORASIB`

ID	`REG-SOTORASIB-KRAS`
Type	Regimen
Status	pending_clinical_signoff
Diseases	None declared
Sources	`SRC-ESMO-NSCLC-METASTATIC-2024` `SRC-NCCN-NSCLC-2025`

Notes

CodeBreaK 100/200: 2L+ KRAS G12C+ NSCLC.

Used By

Indication

IND-NSCLC-2L-KRAS-G12C-SOTORASIB - IND-NSCLC-2L-KRAS-G12C-SOTORASIB
IND-NSCLC-KRAS-G12C-MET-2L - IND-NSCLC-KRAS-G12C-MET-2L